Introduction {#s001}
============

R[ickettsial diseases are among]{.smallcaps} the leading causes of treatable acute febrile illnesses throughout Asia and beyond. Recent studies have established the impact of scrub typhus and murine typhus as causes of acute febrile illness in Thailand (Blacksell et al. [@B2], Thitivichianlert et al. [@B26], Ruang-Areerate et al. [@B20]) and adjacent countries (Phongmany et al. [@B18], Chheng et al. [@B3], Mayxay et al. [@B9], McGready et al. [@B10]). Although pathogens like *Orientia tsutsugamushi* and *Rickettsia typhi* are well described, only limited evidence is available for other zoonotic pathogens contributing to the burden of undifferentiated febrile illness.

Febrile illness attributable to *Coxiella burnetii* and *Bartonella henselae* have been described in Thailand, including recent reports of infective endocarditis for both zoonotic pathogens (Suputtamongkol et al. [@B21], Pachirat et al. [@B11], [@B12], Watt et al. [@B27]). Although *Anaplasma phagocytophilum* (causative agent of human granulocytic anaplasmosis) and *Ehrlichia chaffeensis* (causative agent of human monocytic ehrlichiosis) have been identified in ticks from the Thai--Myanmar border and in Bangkok, to date no human data on seroprevalence or clinical disease is available for these agents (Parola et al. [@B14], Foongladda et al. [@B5]). However, one report provides serological evidence of *E. chaffeensis* infections in a group of healthy volunteers in western Thailand (Heppner et al. [@B6]). Mammalian hosts include rodents, cats, and dogs for *B. henselae* and goats, sheep, and domestic cattle for *Coxiella burnetii* (Bhengsri et al. [@B1], Yingst et al. [@B29]). Clinical and serologic recognition of canine ehrlichiosis among dogs in separated regions of Thailand is established (Davidson et al. [@B4], Jirapattharasate et al. [@B8]).

These data are suggestive that other rickettsial illnesses could contribute to the burden of febrile illness in Thailand (and adjacent regions). Using commercially available kits, this study has determined the immunoglobulin G (IgG) antibody seroprevalence for *C. burnetii*, *B. henselae*, *A. phagocytophilum*, *E. chaffeensis*, and spotted fever group rickettsiae (SFGR) in human patients from well-characterized prospective undifferentiated febrile illness cohorts.

Materials and Methods {#s002}
=====================

A total of 375 serum samples were collected from two febrile illness studies recently performed in Chiangrai (August, 2006, to August, 2007) and Mae Sot, Thailand (March to May, 2011) (Paris et al. [@B13], Watthanaworawit et al. [@B28]). The Chiangrai study previously reported 34% cases with acute scrub typhus infections (*n*=161) and the Mae Sot study (*n*=180) previously reported 3.9% and 6.1% of patients with confirmed acute scrub or murine typhus, respectively (Paris et al. [@B13], Watthanaworawit et al. [@B28]).

The first study recruited 188 hospitalized patients over 15 years old with acute fever of less than 2 weeks duration, no evidence of primary focus of infection, and three negative malaria blood smears. These patients provided written informed consent over one calendar year (August, 2006, to August, 2007) at Chiangrai Prachanukhru hospital. Ethical approval for this study was granted by the local ethics committee of Chiangrai Hospital, the Faculty of Tropical Medicine, Mahidol University, and the Thai Ministry of Public Health.

The second study recruited 187 patients into an undifferentiated fever study between March and August of 2011 at three medical clinics for Burmese migrants and refugees on the Thailand--Myanmar (Burma) border in rural Tak province of northwestern Thailand. Of the three clinics, Wang Pha and Mawker Thai clinics are the two largest and provide health care for the migrant population from Myanmar who live and work along the border. Wang Pha is approximately 30 km north of Mae Sot, whereas Mawker Thai is approximately 60 km south of Mae Sot. The third site was Maela temporary shelter and is the largest camp for refugees from Myanmar on the Thailand--Myanmar border housed in an area of 4 km^2^. This site is located in hills adjoining the Myanmar border, approximately 70 km north of Mae Sot. Patients aged at least 5 years old and presenting to these clinics with an undifferentiated febrile illness were eligible for inclusion in the study. Ethical approval for this study was granted by the Faculty of Tropical Medicine, Mahidol University and the Oxford Tropical Research Ethics Committee (OxTREC), UK.

Serology was performed for the detection of *C. burnetii, E. chaffeensis, B. henselae*, and *A. phagocytophilum* IgG antibodies using indirect immunofluorescence assay (IFA) following the manufacturer\'s instructions for sample testing and interpretation of results in the context of a seroprevalence study, with details provided below. IFA slides were read blinded by two experienced operators. In cases where there was disagreement, a third experienced operator was used to make a final diagnosis.

For the *C. burnetii* IgG IFA (cat. no. QG-120, Fuller Laboratories, Fullerton, CA), samples were screened at a 1:16 dilution against *C. burnetii* phase I and phase II antigens, and positive samples were diluted two-fold from 1:16 to1:256. Acute infection was characterized as samples positive at 1:16 with an end point titer ratio of phase II antigens greater than phase I antigens or a ≥1:256 phase II antigen titer. Chronic or previous infections were characterized by an end point titer ratio of phase I antigens greater than that against the phase II antigen. In this study, samples that met the chronic or previous infection criteria were considered positive.

For the *E. chaffeensis* IgG IFA (cat. no. ECHG-120, Fuller Laboratories, Fullerton, CA), samples were screened at a 1:64 dilution. Positive samples at 1:64 dilution or greater were considered to reflect infection at an undetermined time with *E. chaffeensis* or related organism and were considered positive in the context of this study. The manufacturer noted the limitation that antibodies against *E. canis* and *E. ewingii* can cross-react strongly in this test.

For the *A. phagocytophilum* IgG IFA (cat. no. EEG-120, Fuller Laboratories, Fullerton, CA), samples were screened at a 1:80 dilution and titrated further if positive. Serum titers from 1:80--1:320 suggested titers before or after peak titers associated with *A. phagocytophilum* infection or cross-reactivity with a related organism. In this study, samples with titers ≥1:80 were considered positive. The manufacturer noted the limitation that variable strength cross-reactions with *E. chaffeensis* may occur.

For the *B. henselae* IgG IFA (cat. no. BHG-120, Fuller Laboratories, Fullerton, CA), samples were screened at a 1:64 dilution and titrated further if positive. Serum titers from 1:64 or greater suggest recent or active infection and were considered positive in this study. The manufacturer noted the limitation that other *Bartonella* species may produce type-specific reactions.

Samples were tested for SFGR antibodies using an SFGR EIA IgG Antibody Kit (cat. no. SFG-96K, Fuller Laboratories, Fullerton, CA). Samples were screened at a 1:100 dilution. The manufacturer\'s recommended method for interpretation is as follows, "A Cutoff Calibrator is provided for discrimination between reactive and non-reactive sera. By dividing the OD values of test sera by the OD values of the Calibrator, an index value can be derived where the Calibrator is set at an index of 1.0. Indices from 0.8 to 1.2 may be considered equivocal (assumes %CV of 20%). Indices above 1.2 are then considered positive and those below 0.8 are considered negative." Samples with indices ≥1.2 were considered positive in this study. The manufacturer notes, "This procedure detects group-specific antibody and is, thus, unable to differentiate between the reactivity to various members of the spotted fever group. Reactivity to typhus group or scrub typhus is, in general, not detected."

Statistical analysis was performed using Stata/IC software (v. 13.0, Statacorp, College Station, TX). The command *prtest* was used to compare equality of positivity proportions for significant difference (*p* ≤ 0.05) between study sites. To compare equality of positivity at each age category (0--10 years, 11--20 years, and so on), the Kruskal--Wallis rank test was used.

Results {#s003}
=======

*Ehrlichia* and SFGR were the most common causes of IgG seropositivity at both study sites. The percentages of IgG-positive samples against the specified zoonotic pathogens are presented in [Table 1](#T1){ref-type="table"}. The highest prevalence documented was for *E. chaffeensis* in Mae Sot (60.4%), which was significantly higher (*p*≤0.001) than in Chiangrai (11.7%). Significant differences in antibody prevalence between the study sites were found for *B. henselae* (*p*=0.007; Chiangrai 18.1% *cf.* Mae Sot 8.6%) and *C. burnetii*, (*p*=0.002; Chiangrai 6.4% *cf.* Mae Sot 0.5%). SFGR positivity was relatively high at both sites (Chiangrai 33% *cf.* Mae Sot 27.3%) and not significantly different. *A. phagocytophilum* positivity was similar and relatively low at both sites (Chiangrai 5.3% *cf.* Mae Sot 3.7%).

###### 

[Seroprevalence of IgG against *Coxiella burnetii*, *Ehrlichia chaffeensis*, *Bartonella henselae*, *Anaplasma phagocytophilum*, and Spotted Fever Group Rickettsiae (SFGR) in Patient Samples from Chiangrai and Mae Sot (Total *n*=375)]{.smallcaps}

                                *Chiangrai (*n*=188)*   *Mae Sot (*n*=187)*                                 
  ----------------------------- ----------------------- --------------------- ------------- --------------- ---------------
  *Anaplasma phagocytophilum*   10 (5.3%)               0.478                 7 (3.7%)      0.241           0.464
  *Bartonella henselae*         34 (18.1%)              0.347                 16 (8.6%)     0.457           ***0.007***
  *Coxiella burnetii*           12 (6.4%)               ***0.025***           1 (0.5%)      0.309           ***0.002***
  *Ehrlichia chaffeensis*       22 (11.7%)              0.664                 113 (60.4%)   0.094           ***\<0.001***
  SFGR                          62 (33.0%)              0.758                 51 (27.3%)    ***\<0.001***   0.229

Values in ***bold italics*** indicate that that they are statistically significant (*p* ≤ 0.05).

IgG, immunoglobulin G.

Multiple positivity or evidence of IgG antibody for more than one infection per person was found in 15% and 25% of cases with multiple seropositivity at Chiangrai and Mae Sot, respectively, and 3% of all cases with evidence for triple seropositivity ([Table 2](#T2){ref-type="table"}). The most common multiple positivity ([Table 3](#T3){ref-type="table"}) in Chiangrai was SFGR/*B. henselae* (8.5%) and in Mae Sot SFGR/*E. chaffeensis* (20.2%).

###### 

[Percentage of Patients with Multiple Seropositive Results from the Chiangrai and Mae Sot Sites]{.smallcaps}

      *Number (%) of patients with multiple seropositive results*   
  --- ------------------------------------------------------------- ------------
  0   89 (47.3%)                                                    57 (30.5%)
  1   65 (34.6%)                                                    78 (41.7%)
  2   28 (14.9%)                                                    46 (24.6%)
  3   5 (2.7%)                                                      6 (3.2%)
  4   1 (0.5%)                                                      0

###### 

[Multiple Seropositivity at the Chiangrai and Mae Sot Study Sites]{.smallcaps}

                                 *Mae Sot (*n*=187)*                                   
  ------------------------------ --------------------- ---------- --------- ---------- -----------
  Chiangrai (*n*=188)                                                                  
   *Anaplasma phagocytophilum*   ---                   0          1 (0.5)   7 (3.7)    1 (0.5)
   *Bartonella henselae*         2 (1.1)               ---        0         10 (5.3)   6 (3.2)
   *Coxiella burnetii*           0                     1 (0.5)    ---       1 (0.5)    0
   *Ehrlichia chaffeensis*       6 (3.2)               6 (3.2)    1 (0.5)   ---        38 (20.2)
   SFGR                          4 (2.2)               16 (8.5)   3 (1.6)   8 (4.3)    ---

This table summarizes the multiple seropositivity results found at the two study sites. The upper right triangle of data represents positive results from Mae Sot, whereas the lower left triangle represents Chiangrai. Data are actual numbers, with percentages shown in parentheses.

A distinct relationship between age and seropositivity was found in Chiangrai, with acquisition of IgG titers against *E. chaffeensis*, *B. henselae*, *A. phagocytophilum*, and SFGR rising rapidly between 30--40 years of age. At Mae Sot, seroprevalences manifested similarly with high early IgG titers against *E. chaffeensis* and SFGR positivity peaking around 40 years, but *B. henselae* and *A. phagocytophilum* IgG titers rising later at 50 years of age ([Fig. 1](#f1){ref-type="fig"}). Mae Sot SFGR seropositivity per age group demonstrated a significant difference at 20--30 years, the age of peak rural activity, when compared to Mae Sot (*p*≤0.001).

![Age group seroprevalence of *C. burnetii*, *E. chaffeensis*, *B. henselae*, *A. phagocytophilum*, and SFGR IgG titers in patient samples from Mae Sot (**A**) and Chiangrai (**B**). MS QF, Mae Sot Q fever; MS E, Mae Sot *Ehrlichia*; MS BT, Mae Sot *Bartonella*; MS A, Mae Sot *Anaplasma*; MS SFG, Mae Sot spotted fever group rickettsiae; CR QF, Chiangrai Q fever; CR E, Chiangrai *Ehrlichia*; CR BT, Chiangrai *Bartonella*; CR A, Chiangrai *Anaplasma*; CR SFG, Chiangrai spotted fever group rickettsiae.](fig-1){#f1}

Seroprevalence of IgG against *C. burnetii* results was demonstrated following variations of antibodies associated with infection phase; one, nine, and five patients showed evidence of antibodies against phase I, phase II, and both phases antigens, respectively, at Chiangrai and a single patient at Mae Sot was positive for both infection phases. These findings are suggestive that approximately 5% (9/190) of febrile patients in Chiangrai could have presented with active infections. Q fever was generally associated with low IgG positivity across the age groups at both study sites; however, a significantly higher prevalence was observed at 30 years of age in Chiangrai (*p*=0.025).

Discussion {#s004}
==========

This study provides human seroprevalence data on hitherto poorly described zoonotic pathogens at two study sites in Thailand. The finding of *E. chaffeensis,* SFGR, and also *B. henselae* as the most common causes of IgG seropositivity in this study suggests that these pathogens should be considered in the differential diagnosis of undifferentiated febrile illness. In view of the easily treatable nature of these diseases, further clinical investigations of these potentially serious infections are warranted, and future studies addressing "causes of illness" attributable to these pathogens should consider diagnostics with a high level of confidence, such as culture, molecular tools, and/or paired serology, if possible, combined with subsequent molecular characterization (Phommasone et al. [@B17]).

Significant differences in antibody prevalence between the study sites were found for *B. henselae*, *C. burnetii*, and *E. chaffeensis*. Furthermore, there was a distinct relationship between age and seropositivity for *A. phagocytophilum, B. henselae, E. chaffeensis*, and SFGR in this study ([Table 1](#T1){ref-type="table"} and [Fig.1](#f1){ref-type="fig"}). The stratification of IgG titers into age groups highlighted that patients increased their exposure to these pathogens and acquired IgG antibodies over time. The humoral responses to SFGR and *E. chaffeensis* dominated in early adulthood in the Mae Sot region, when exposure to rural activities is highest. However these titers remained high, suggestive of either continuous exposure and/or high longevity of antibodies. In contrast, low positivity rates were followed by a distinct increase in anti--*B. henselae* IgG seropositivity in the oldest age group. *A. phagocytophilum* and *C. burnetii* titers were generally low in the Mae Sot samples, whereas in Chiangrai *A. phagocytophilum* responses increased early, but not *C. burnetii*, which after a seropositivity peak at 20--30 years of age, dropped to zero in older patients. In the Chiangrai population all patients had previous exposure to *A. phagocytophilum*, *E. chaffeensis*, *B. henselae*, and SFGR by the age of 40, which is suggestive that these pathogens are more common than previously assumed.

Previous studies have examined the seroprevalence of rickettsial illnesses in Malaysia and provide evidence for murine typhus and SFGR exposure to be very common (Tay et al. [@B23], Tay and Rohani [@B22], Tay et al. [@B24]). Age groups under 21 years old had a lower seroprevalence of SFGR compared with the other age groups, similar to our observations, and very high seropositivity rates for SFGR were associated with rubber estate workers (Tee et al. [@B25]). In addition, other studies have also identified spotted fever group organisms in fever patients and vectors in similar locations, and therefore our results confirmed that SFGR are likely to contribute to the disease burden of undifferentiated fevers and should be a concern to people who live or visit these areas (Tay et al. [@B24], Parola et al. [@B15], Parola et al. [@B16], Pickard et al. [@B19], Jiang et al. [@B7]).

Patients with multiple seropositivity results to the evaluated pathogens were common and underline the cumulative exposure over time ([Table 2](#T2){ref-type="table"}). There was no statistically significant difference in the rates of IgG acquisition status between the sites (χ^2^ *p*=0.465). Overall, 30.5--47.3% of patients were seronegative at both sites for antibodies against the agents of the arthropod-borne diseases tested, whereas the majority of patients had either one (34.6--41.7%) or two (14.9--24.6%) seropositive results. Seropositivity was rare for either three (2.7--3.2%) or four diseases (0.5% in Chiangrai) ([Table 2](#T2){ref-type="table"}).

Although the longevity of IgG antibodies is not well established in these regions and reversion rates to seronegativity remain to be determined, it is likely that the increasing seropositivity rates across the age groups reflect a high level of cumulative exposure, as the IgG antibodies for these infections are normally long-lived and probably get "boosted" intermittently in endemic areas. In contrast, a high seroreversion rate would mean that the data represent an underestimation, due to the proportion of "false negatives" resulting from reversion to seronegativity. Interestingly, the seropositivity rates for anti--*C. burnetii* IgG antibodies in Chiangrai and the anti-SFGR IgG antibodies in Mae Sot declined in older age groups. Whether this phenomenon is attributable to increased seroreversion and whether loss of antibody over time occurs need to be investigated further ([Fig. 1](#f1){ref-type="fig"}). In contrast, *E. chaffeensis* infections seem to be more prevalent from an early age in Mae Sot and tend to stay high into adulthood ([Fig. 1](#f1){ref-type="fig"}).

Although this study was based on two well-characterized prospective patient cohorts, some limitations must be considered. First, the inclusion of febrile patients from hospitals may not accurately represent the typical cross-sectional findings of healthy populations because the active treatment--seeking behavior associated with hospitalized patients could associate with bias, *i.e*., a significant proportion of infections result in subclinical disease with manifestations that do not warrant seeking medical care. Second, the populations enrolled may not represent well the populations found throughout the northern and northwestern regions or that of Thailand as a whole. Third, serological cross-reactions between and within genera should be considered when interpreting results. The manufacturer clearly states in the product literature that the possibility of cross-reaction (false positivity) caused by *E. chaffeensis* antibodies in the *A. phagocytophilum* IFA, and the manufacturer highlighted that *E. chaffeensis* and *B. henselae* IFAs are not species-specific and positivity may be due to other members of the genera.

The data presented here highlight that etiologies of tropical rickettsial illnesses need to be considered beyond *O. tsutsugamushi* and *R. typhi*; however, the contribution of these pathogens to the burden of undifferentiated febrile illness in Thailand and potentially adjacent regions requires further clinical studies.

Conclusion {#s005}
==========

Our seroprevalence data suggest that other zoonotic pathogens could contribute to the burden of tropical rickettsial illnesses in Thailand and possibly adjacent regions. Improved diagnostics and better understanding of antibody longevity and cross-reactivity are necessary and will improve identification and management of these easily treatable but potentially serious infectious diseases.
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